Protalix BioTherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 971 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 601-625 of 685 matching filings.

Per page
25
Current page
25
8-K File 001-33357

FORM 8-K

Filing date
01 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
10 Nov 2011
Reporting date
10 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
08 Nov 2011
Reporting date
07 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
26 Oct 2011
Reporting date
26 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-33357

AUTO-GENERATED PAPER DOCUMENT

Filing date
23 Sep 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
21 Sep 2011
Reporting date
21 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEFINITIVE PROXY STATEMENT

Filing date
19 Sep 2011
Reporting date
07 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K filing

Filing date
13 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
08 Sep 2011
Reporting date
08 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
17 Aug 2011
Reporting date
17 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K filing

Filing date
01 Aug 2011
Reporting date
01 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K filing

Filing date
15 Jun 2011
Reporting date
15 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
12 May 2011
Reporting date
12 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33357

FORM 10-Q

Filing date
04 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
27 Apr 2011
Reporting date
27 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
07 Apr 2011
Reporting date
07 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-33357

FORM 8-K/A

Filing date
23 Mar 2011
Reporting date
17 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171615

424B5

Filing date
18 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
18 Mar 2011
Reporting date
17 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-171615

424B5

Filing date
17 Mar 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
17 Mar 2011
Reporting date
17 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
25 Feb 2011
Reporting date
25 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-33357

FORM 10-K

Filing date
23 Feb 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .